Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/14/2021
Reform Has Unleashed Chinese Drugs Innovation Boom, Though Some Pharma...
1/14/2021
What Do Novartis Deal, PD-1 Competition In China Mean For Tislelizumab...
1/14/2021
Pharma Companies to Cut Prices of News Drugs by 51% to Access Chinese ...
1/14/2021
Novartis, Once Wary of Chinese M&A, Dives into BeiGene's Cancer Immuno...
1/13/2021
NMPA Issues the Measures for Post Marketing Changes of Drug Products
1/13/2021
Domestic PD-1s in the 2020 NRDL Negotiated Entry: Winners Take All
1/13/2021
PharmCube: Top 15 Innovative Drug In-licensing Deals by Chinese Pharma...
1/13/2021
Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum in C...
1/13/2021
BeiGene Granted Chinese Approval of Tislelizumab in Combo with Chemoth...
1/13/2021
Gracell Approved to Begin Phase 1/2 Trial of CAR-T GC007g for Leukem...
1/12/2021
Qilian International Debuts on Nasdaq
1/12/2021
Swiss Re Sees Short-term Health insurance as Growth Driver in China
1/11/2021
VISEN Pharma Closes $150M Series B Financing for Novel Endocrinology D...
1/11/2021
Novartis and BeiGene in $2.2B Deal Latter's Promising Checkpoint Inhi...
1/11/2021
Chi-Med and Inmagene Announce Partnership for Portfolio of Drug Candi...
1/11/2021
Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid ...
1/11/2021
Chipscreen Files Pivotal PIII Trial IND Submission for Anticancer Chia...
1/11/2021
NHSA Issues Two Interim Rules for Management of BMI Designated Medical...
1/8/2021
VISEN Pharma Granted IND Approval for P2 Trial of Achondroplasia Drug...
1/8/2021
Allecra and Haini Pharma Enter Licensing Deal for Cefepime/Enmetazob...
1/8/2021
Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...
1/8/2021
HLB's Liver Cancer Drug Wins Marketing Approval in China
1/8/2021
Abbisko Raises $123 Million From Carlyle, Warburg
1/8/2021
European Firms Eye Chinese Assets in Mainly Insurance and Healthcare...
1/8/2021
Recent Executive Moves
1/8/2021
SMCP - Coronavirus in China: 2021 Outlook Brightens for Health Care Op...
1/8/2021
S&P Global: China's Big Tech to Continue Disruption of Healthcare Sect...
1/7/2021
Economic Burden and Health Care Access for Patients with IBD in China:...
1/7/2021
China Issues Announcement on the 2021 Doping List (#51)
1/7/2021
Apollomics Granted Breakthrough Therapy Designation for AML Drug APL-1...
Page:
203
/
774
Total number of articles:
23194
:
[First]
[<<]
[201]
[202]
[203]
[204]
[205]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit